<DOC>
	<DOCNO>NCT01038583</DOCNO>
	<brief_summary>The ASPREE study examine whether potential benefit low dose aspirin ( particularly prevent heart disease , stroke , certain cancer dementia ) outweigh risk ( particularly bleed ) people age 65 . ASPREE determine whether take daily low-dose aspirin extend length disability-free life healthy participant age 65 year .</brief_summary>
	<brief_title>Aspirin Reducing Events Elderly</brief_title>
	<detailed_description>Low dose aspirin therapy show reduce risk vascular event , largely middle-aged people . There also evidence potential reduce rate intellectual decline certain type cancer old participant . However , part benefit aspirin may offset adverse effect , relate potential cause bleeding . The balance risk benefit low dose aspirin establish old person . Previous study effect aspirin primary prevention mainly focus cardiovascular outcome . In elderly , alone may appropriate measure benefit associate aspirin treatment . Prolonging life free functional disability healthy age population would desirable benefit aspirin preventative medicine . ASPREE determine whether take daily low-dose aspirin extend length disability-free life healthy participant age 65 year .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Men woman African American Hispanic person age 65 old Any person another ethnic minority group Caucasian person age 70 old Willing able provide inform consent , willing accept study requirement A history diagnose cardiovascular event A serious intercurrent illness likely cause death within next 5 year , terminal cancer obstructive airway disease A current recurrent condition high risk major bleeding , ex : cerebral aneurysm Anemia Absolute contraindication allergy aspirin Current participation clinical trial Current continuous use aspirin antiplatelet drug anticoagulant secondary prevention . People previous use aspirin primary prevention may enter trial , provide agree cease exist use aspirin understand may subsequently randomly allocate low dose aspirin placebo . A systolic blood pressure ≥180 mmHg / diastolic blood pressure ≥105 mmHg A history dementia Severe difficulty inability perform one 6 Katz ADLs Noncompliance take pill</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Aspirin</keyword>
	<keyword>Prevention</keyword>
	<keyword>Healthy</keyword>
	<keyword>Over 65 year old</keyword>
	<keyword>ASPREE</keyword>
	<keyword>Aspirin Reducing Events Elderly</keyword>
	<keyword>Australia</keyword>
	<keyword>Functional disability</keyword>
	<keyword>Dementia</keyword>
	<keyword>Heart Disease/ Stroke</keyword>
	<keyword>Cancer</keyword>
	<keyword>Bleeding</keyword>
</DOC>